Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran; Cellular and Molecular Nutrition Department, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
Mult Scler Relat Disord. 2018 Feb;20:43-47. doi: 10.1016/j.msard.2017.12.015. Epub 2017 Dec 24.
Several studies have suggested that the existence of a history of multiple sclerosis (MS) in family, is one of the predisposing factors for MS. Based on our knowledge, the review and estimation of the prevalence of familial multiple sclerosis (FMS) in the world has not been reported up to now. This study is a systematic review and a meta-analysis of FMS prevalence in the world.
Two researchers searched "epidemiology" or "prevalence" or "incidence" and "familial multiple sclerosis" as relevant keywords in international databases such as PubMed, web of science and Scopus up to 2016. MedCalc Version 15.8 was used to estimate the pooled prevalence of FMS. (PROSPERO ID = CRD42016033016) RESULTS: From the 184 total articles found from 1954 to 2016, we pooled and analyzed the data of 17 final eligible studies, according to the inclusion criteria. The prevalence of FMS was estimated as 12.6% within a total sample size of 14,619 MS patients in the world as of 95% confidence interval (CI: 9.6-15.9).
We detected significant heterogeneity from Hungary to Saskatchewan for FMS prevalence that was not latitude and ethnicity dependent. This highlighted the accumulation effects of genetic and environment on FMS prevalence. Pooled prevalence of FMS in MS population was calculated 12.6% by random effect in the world.
多项研究表明,多发性硬化症(MS)家族史是 MS 的一个诱发因素。据我们所知,目前尚未有关于全球家族性多发性硬化症(FMS)患病率的综述和评估。本研究是对全球 FMS 患病率的系统综述和荟萃分析。
两名研究人员在 PubMed、Web of Science 和 Scopus 等国际数据库中以“流行病学”或“患病率”或“发病率”和“家族性多发性硬化症”为相关关键字进行了搜索,截至 2016 年。使用 MedCalc Version 15.8 估计 FMS 的汇总患病率。(PROSPERO ID = CRD42016033016)
从 1954 年至 2016 年共检索到 184 篇文章,根据纳入标准对 17 项最终合格研究进行了汇总和分析。全球共有 14619 名 MS 患者,FMS 的患病率估计为 12.6%,置信区间为 95%(9.6-15.9)。
我们从匈牙利到萨斯喀彻温省检测到 FMS 患病率存在显著异质性,这与纬度和种族无关。这突出了遗传和环境对 FMS 患病率的累积影响。通过随机效应,全球 MS 人群中 FMS 的汇总患病率为 12.6%。